If you are over 65, you should not get this new vaccine, experts warn

In the US, there are two approved COVID vaccines – one from Pfizer and another from Moderna – that are administered to anyone older than 16 and 18 years old. However, according to the Centers for Disease Control & Prevention (CDC) recommendation, early priority was given to those over 75 because they are particularly vulnerable to serious diseases due to COVID. Two new vaccines are now available in the US – one from Johnson & Johnson and one from AstraZeneca. The latter is already used in the UK and half a dozen other countries. However, German officials have just issued a statement saying they do not recommend the AstraZeneca vaccine for the most susceptible group – people over 65 years of age. Read on for more information on vaccines to see why the elderly should take this vaccine. from The Grim COVID Rumor the White House has just confirmed.

Read the original article Best life.

Microsoft may earn you a branch commission if you purchase something through recommended links in this article.

The experts say the AstraZeneca vaccine should not yet be used for people over 65.

According to CNN, the German Vaccine Commission on January 28 recommended that the AstraZeneca vaccine not be given to people over the age of 65, according to a statement from the German Interior Ministry. The statement cited a study conducted by the Standing Committee on Vaccination at the Robert Koch Institute in Germany, and found that there are insufficient data on the efficacy of the vaccine for this specific age group. Under their advice, the vaccine should only be offered to people between the ages of 18 and 65. And for more up-to-date COVID news delivered directly to your inbox, you can sign up for our daily newsletter.

Microsoft may earn you a branch commission if you purchase something through recommended links in this article.

AstraZeneca did not include enough elderly people in the initial clinical trials.

The German Ministry of Health has expressed concern that not enough elderly people were included in the initial AstraZeneca vaccine trial to consider it safe and effective for the population. According to The guardian, Jens SpahnThe German Federal Minister of Health said in a statement: “It has been known since the autumn that fewer elderly people were included in the trials provided by AstraZeneca than the trials of other manufacturers.” Without comprehensive trial data on people over 65, experts are concerned about how the vaccine will affect the population. And for more precautions you need to take, check out why dr. Fauci says that it is a big mistake to do this after being vaccinated.

Microsoft may earn you a branch commission if you purchase something through recommended links in this article.

The AstraZeneca vaccine has a lower efficacy rate than that of Pfizer and Moderna.

The AstraZeneca vaccine has been widely used abroad, but there have been a few cases that have called into question its effectiveness. According to the Australian Broadcasting Company, the effectiveness of the AstraZeneca vaccine during trials was around 7 per cent, significantly lower than Pfizer and Moderna, both of which boast efficiency rates close to 95 per cent. For another update of the vaccine from one of the companies, you need to find out why the CEO of Moderna just made this narrow prediction about COVID.

Microsoft may earn you a commission if you purchase something through the links provided in this article.

The AstraZeneca vaccine is likely to be approved in the US in the spring.

AstraZeneca will probably only be able to apply for approval for the vaccine in the USA in the spring, Business Insider reports. During the original trial, a portion of the participants over 55 were mistakenly given half a dose annually for their first shot. As a result of this error, AstraZeneca is awaiting the results of a larger US trial to submit information to the Food and Drug Administration (FDA). Registration for AstraZeneca’s US trial of 30,000 people began in September and Phase 3 is currently underway. The results of the test will hopefully prove that the vaccine is effective for those over 65.

After FDA approval, the vaccine must also be approved by the CDC’s Advisory Committee on Immunization Practices (ACIP), which means we are unlikely to see this vaccine early in the summer. To see what side effects may occur with your second dose, go to dr. Fauci and says he has these side effects from his second vaccine dose.

Microsoft may earn a branch commission if you purchase something through recommended links in this article.

5/5 SLIDES